Literature DB >> 23290310

Influence of mode of stress and coronary risk factor burden upon long-term mortality following normal stress myocardial perfusion single-photon emission computed tomographic imaging.

Azhar Supariwala1, Seth Uretsky, E Gordon Depuey, Gargi Thotakura, Sirisha Kanneganti, Narasimhanaidu Guriginjakunta, Radhika Vala, Mahesh Kuruba, Alan Rozanski.   

Abstract

In patients with normal results on stress single-photon emission computed tomographic (SPECT) studies, coronary artery disease risk factors (RFs) and the mode of testing can influence the trajectory of long-term outcomes. Nevertheless, the combined prognostic impact of these commonly assessed factors has heretofore not been considered. In this study, all-cause mortality rates were assessed in 5,762 patients with normal results on stress SPECT studies. Patients were divided according to mode of stress testing, exercise or pharmacologic, and by number of coronary artery disease RFs. Patients were followed for a mean of 8 ± 4.2 years for all-cause mortality. There were 1,051 deaths (18%), with an annualized mortality rate of 2.2% per year. The RF-adjusted event rate was significantly higher for pharmacologic versus exercise SPECT studies (3.6% per year vs 1.2% per year, p <0.0001) and for patients with increasing numbers of coronary artery disease RFs (p <0.0001). Kaplan-Meier survival analysis revealed wide heterogeneity in all-cause mortality rates when RF burden and performance of exercise versus pharmacologic testing were considered, ranging from only 0.8% per year in exercise patients with no RFs to 4.2% per year in pharmacologic patients with ≥2 RFs. Mortality rates in exercise patients with ≥2 RFs were comparable to those in pharmacologic patients with no RFs. In conclusion, long-term outcomes after cardiac stress testing are synergistically and strongly influenced by RF burden and inability to exercise. Given these findings, prospective study is indicated to determine whether enhanced risk categorization that combines the consideration of these 2 factors improves patient counseling and physician risk management among patients manifesting normal results on stress SPECT studies.
Copyright © 2013. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23290310     DOI: 10.1016/j.amjcard.2012.11.040

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  8 in total

1.  Long-term outcomes following a normal stress myocardial perfusion scan.

Authors:  Seth Uretsky; Alan Rozanski
Journal:  J Nucl Cardiol       Date:  2013-10       Impact factor: 5.952

2.  Beyond ischemia evaluation: The potential for assessing and addressing physical inactivity in the cardiac stress laboratory.

Authors:  Seth Uretsky
Journal:  J Nucl Cardiol       Date:  2016-04       Impact factor: 5.952

3.  Negative predictive value of stress myocardial perfusion imaging and coronary computed tomography angiography: A meta-analysis.

Authors:  Roberta Green; Valeria Cantoni; Mario Petretta; Wanda Acampa; Mariarosaria Panico; Pietro Buongiorno; Giorgio Punzo; Marco Salvatore; Alberto Cuocolo
Journal:  J Nucl Cardiol       Date:  2017-02-15       Impact factor: 5.952

4.  Value-based imaging: Combining coronary artery calcium with myocardial perfusion imaging.

Authors:  Daniel S Berman; Alan Rozanski
Journal:  J Nucl Cardiol       Date:  2016-08-18       Impact factor: 5.952

5.  Warranty periods for normal myocardial perfusion stress SPECT.

Authors:  Guillermo Romero-Farina; Jaume Candell-Riera; Santiago Aguadé-Bruix; Ignacio Ferreira-González; Gemma Cuberas-Borrós; Nazarena Pizzi; David García-Dorado
Journal:  J Nucl Cardiol       Date:  2014-08-13       Impact factor: 5.952

6.  Comparison of diabetes to other prognostic predictors among patients referred for cardiac stress testing: A contemporary analysis from the REFINE SPECT Registry.

Authors:  Daniel S Berman; Piotr J Slomka; Donghee Han; Alan Rozanski; Heidi Gransar; Evangelos Tzolos; Robert J H Miller; Tali Sharir; Andrew J Einstein; Mathews B Fish; Terrence D Ruddy; Philipp A Kaufmann; Albert J Sinusas; Edward J Miller; Timothy M Bateman; Sharmila Dorbala; Marcelo Di Carli; Joanna X Liang; Lien-Hsin Hu; Damini Dey
Journal:  J Nucl Cardiol       Date:  2021-11-10       Impact factor: 3.872

Review 7.  The Synergistic Use of Coronary Artery Calcium Imaging and Noninvasive Myocardial Perfusion Imaging for Detecting Subclinical Atherosclerosis and Myocardial Ischemia.

Authors:  Alan Rozanski; Daniel S Berman
Journal:  Curr Cardiol Rep       Date:  2018-06-13       Impact factor: 2.931

8.  Beyond traditional cardiovascular risk factors: Could frailty and other morbidities explain the worse prognosis in patients undergoing pharmacologic stress?

Authors:  Patricia Rodriguez Lozano; Jamieson M Bourque
Journal:  J Nucl Cardiol       Date:  2020-11-25       Impact factor: 5.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.